Back
  1. Home
  2. Profile of Benjamin KOOPMANSCH (ULiège)
Profil

KOOPMANSCH Benjamin

Unilab > Unité de laboratoire - oncologie et hématologie

See author's contact details
Main Referenced Co-authors
Lambert, Frédéric  (15)
Bours, Vincent  (8)
Delvenne, Philippe  (6)
Fernandez Carazo, Rafael  (5)
Peulen, Olivier  (5)
Main Referenced Keywords
Humans (2); KLF4 (2); 18F-FDG PET/CT (1); acute myeloid leukemia (1); AKT signaling (1);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège (3)
GIGA‐R - Giga‐Research - ULiège (1)
Main Referenced Disciplines
Oncology (8)
Biochemistry, biophysics & molecular biology (7)
Hematology (4)
Genetics & genetic processes (4)
Endocrinology, metabolism & nutrition (1)

Publications (total 24)

The most downloaded
1916 downloads
JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276. https://hdl.handle.net/2268/184321

The most cited

176 citations (OpenAlex)

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5 https://hdl.handle.net/2268/216166

Reynders, C., Bruyère, D., RONCARATI, P., Geuzaine, R., KOOPMANSCH, B., Gofflot, S., Monnien, F., Craciun, L., Piazzon, N., Hendrick, E., Poulain, F., Lerho, T., Miceli, S., Pilard, C., Ancion, M., Luyckx, M., Renard, M., Lambert, F., Gheit, T., ... Herfs, M. (December 2025). Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma. Modern Pathology, 38 (12), 100853. doi:10.1016/j.modpat.2025.100853
Peer Reviewed verified by ORBi

Lopez Delhoulle, V., De Voeght, A., NECHIFOR - POTORAC, I., Sépulchre, E., Willems, E., Pétrossians, P., Fernandez Carazo, R., KOOPMANSCH, B., Docampo Martínez, E., Bours, V., Bulk, S.* , & Lambert, F.*. (16 October 2025). A Spectrum of Tumorigenesis in an IDH1-Mosaic Patient with Ollier Disease [Poster presentation]. 7th INTERNATIONAL CONFERENCE ACUTE MYELOID LEUKEMIA “MOLECULAR AND TRANSLATIONAL”: ADVANCES IN BIOLOGY AND TREATMENT, Estoril, Portugal.
Peer reviewed
* These authors have contributed equally to this work.

De Voeght, A.* , KOOPMANSCH, B.* , MENTEN, C., Fernandez Carazo, R., Keutgens, A., Tassin, F., Somja, J., Collins, P., SIMUL, M., DE PRIJCK, B., Foguenne, J.* , & LETE, C.*. (07 February 2025). Aggressive Hematological Neoplasms Involving Plasmacytoid Dendritic Cells: A Three-Case Serie [Poster presentation]. 40th General Annual Meeting of the Belgian Hematology Society 2025.
Editorial reviewed
* These authors have contributed equally to this work.

Nokin, M.-J., Darbo, E., Richard, E., San José, S., de Hita, S., Prouzet-Mauleon, Turcs, B., Gerardelli, L., Crake, R., Velasco, V., KOOPMANSCH, B., Lambert, F., Xue, J. Y., Sang, B., Horne, J., Ziemons, E., Villanueva, A., Blomme, A., Herfs, M., ... Santamaria, D. (2024). In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma. Cell Reports Medicine. doi:10.1016/j.xcrm.2024.101663
Peer Reviewed verified by ORBi

Catarin, N., LETE, C., Fernandez Carazo, R., KOOPMANSCH, B., Franke, S., LLORENTE, W., GUADAGNI, A., Bours, V., Beckers, P., JAMAR, M., Lambert, F., & MENTEN, C. (2024). Optical genome mapping (Bionano – Saphyr) for AML associated with cryptic chromosomal recurrent abnormality. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414
Peer Reviewed verified by ORBi

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

FERNANDEZ CARAZO, R., KOOPMANSCH, B., PALMEIRA, L., CHARLOTEAUX, B., & LAMBERT, F. (2020). Hematopoietic Malignancies with Germline Predisposition Diagnosis with Filtered Whole Exome Sequencing and in silico Panel Analysis [Poster presentation]. European School of Haematology 2020.

DELPORTE, G., Delcorde, I., RORIVE, A., JEUGMANS, A.-M., MOONEN, M., KOOPMANSCH, B., Moonen, G., & Delvenne, P. (2020). Cas clinique. Maladie d’Erdheim-Chester. Revue Médicale de Liège, 75 (4), 213-217.

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366
Peer Reviewed verified by ORBi

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2
Peer Reviewed verified by ORBi

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5
Peer Reviewed verified by ORBi

SAGOT, C., CHARLIER, H., KOOPMANSCH, B., & LAMBERT, F. (29 January 2016). Two cases of atypical CALR mutations in MPN patients [Poster presentation]. BHS General annual meeting 2016.

KOOPMANSCH, B., LOPEZ Y CADENAS, M., Hennuy, B., & LAMBERT, F. (29 January 2016). Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia [Poster presentation]. BHS General Annual Meeting 2016, United States - Texas.

LOVINFOSSE, P., KOOPMANSCH, B., LAMBERT, F., JODOGNE, S., KUSTERMANS, G., Hatt, M., Visvikis, D., SEIDEL, L., POLUS, M., Albert, A., DELVENNE, P., & HUSTINX, R. (2016). 18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. British Journal of Radiology, 20160212. doi:10.1259/bjr.20160212
Peer Reviewed verified by ORBi

DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6.

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.
Peer reviewed

Koopmansch, B. (2013). Contribution à l'étude des mécanismes transcriptionnels du facteur de transcription SIP1/ZEB2 [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/145015

Koopmansch, B., Berx, G., Foidart, J.-M., Gilles, C., & Winkler, R. (22 February 2013). Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Biochemical and Biophysical Research Communications, 431 (4), 652. doi:10.1016/j.bbrc.2013.01.070
Peer reviewed

Koopmansch, B. (18 April 2012). Interactions of KLF4 and SIP1 in the regulation of E-Cadherin expression [Poster presentation]. Biomedica 2012.

Koopmansch, B. (19 May 2011). dentification of SIP1-modulated genes during the epithelial-to-mesenchymal transition and interactions with KLF factors in EMT control [Poster presentation]. GIGA-Cancer Day.

Nolens, G., Pignon, J.-C., Koopmansch, B., Elmoualij, B., Zorzi, W., De Pauw, E., & Winkler, R. (11 November 2009). Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines. Breast Cancer Research, 11 (6). doi:10.1186/bcr2450
Peer Reviewed verified by ORBi

Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760
Peer Reviewed verified by ORBi

Contact ORBi